Recent Articles of Interest

Weiss AJ (Truven Health Analytic), Elixhauser A (AHRQ), Barrett ML (M.L. Barrett, Inc.), Steiner CA (AHRQ), Bailey MK (Truven Health Analytics), O'Malley L (Truven Health Analytics). Opioid-Related Inpatient Stays and Emergency Department Visits by State, 2009-2014. HCUP Statistical Brief #219. December 2016. Agency for Healthcare Research and Quality, Rockville, MD. http://www.hcup-us.ahrq.gov/reports/statbriefs/sb219-Opioid-Hospital-Stays-ED-Visits-by-State.pdf. 

Walsh SL, Comer SD, Lofwall MR, Vince B, Levy-Cooperman N, Kelsh D, Coe MA, Jones JD, Nuzzo PA, Tiberg F, Sheldon B. Effect of Buprenorphine Weekly Depot (CAM2038) and Hydromorphone Blockade in Individuals With Opioid Use Disorder: A Randomized Clinical Trial. JAMA psychiatry. 2017 Jun 22.

Clemans-Cope, Lisa, Marni Epstein, and Genevieve M. Kenney. "Rapid Growth in Medicaid Spending on Medications to Treat Opioid Use Disorder and Overdose." (2017).

Sharfstein JM. The Opioid Crisis From Research to Practice. The Milbank Quarterly. 2017 Mar 1;95(1):24-7.

Botticelli MP, Koh HK. Changing the language of addiction. Jama. 2016 Oct 4;316(13):1361-2.

Amato L, Minozzi S, Davoli M, Vecchi S. Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. The Cochrane Library. 2011 Jan 1.

Karen D. Ersche,  P. Simon Jones, Guy B. Williams, Abigail J Turton, Trevor W. Robbins, Edward T. Bullmore. Abnormal Brain Structure Implicated in Stimulant Drug Addiction SCIENCE VOL 335, 3 FEBRUARY 2012. 

Tetrault JM, Green ML, Martino S, Thung SF, Ryan SA, Martel S, Pantalon MV, Bernstein SL, O'Connor PG, Fiellin DA, D'Onofrio G. Developing and Implementing a Multi-specialty Graduate Medical Education Curriculum on Screening, Breif Intervention and Referral to Treatment (SBIRT) Substance Abuse 2012

Connecticut Battles Opiate Addiction with Science    

Author: Brian Sullivan

New Haven, Conn. - A new clinical study is one way Connecticut is getting to the bottom of a serious problem that crosses all economic, social and racial boundaries - opiate addiction. Prescription drugs, percocet and lortab issued for acute pain such as an injury and chronic pain associated with a debilitating disease are more and more developing into addictions for the patients they are given to. What’s worse - after the well of painkillers runs out for the addicted, a common alternative is the cheaper and more accessible. One doctor we talked to at Yale University has dedicated much time and effort in finding a solution to the epidemic.